ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,016,000 | +35.1% | 775,246 | +81.6% | 0.00% | -50.0% |
| Q4 2021 | $752,000 | +28.8% | 427,008 | +58.8% | 0.00% | +100.0% |
| Q3 2021 | $584,000 | -23.7% | 268,953 | +23.1% | 0.00% | -50.0% |
| Q2 2021 | $765,000 | -59.9% | 218,405 | +12.9% | 0.00% | -71.4% |
| Q1 2021 | $1,907,000 | +66.7% | 193,470 | +83.4% | 0.01% | +75.0% |
| Q4 2020 | $1,144,000 | +64.8% | 105,519 | +56.7% | 0.00% | +33.3% |
| Q3 2020 | $694,000 | -27.9% | 67,329 | +46.1% | 0.00% | -50.0% |
| Q2 2020 | $962,000 | +353.8% | 46,089 | +112.5% | 0.01% | +200.0% |
| Q1 2020 | $212,000 | -4.5% | 21,691 | +12.2% | 0.00% | +100.0% |
| Q4 2019 | $222,000 | +138.7% | 19,325 | +13.5% | 0.00% | 0.0% |
| Q3 2019 | $93,000 | – | 17,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |